Liabilities, Current of EAGLE PHARMACEUTICALS, INC. from 30 Sep 2013 to 30 Jun 2023
- Taxonomy & unit
- us-gaap: USD
- Description
- Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
- Summary
-
EAGLE PHARMACEUTICALS, INC. quarterly Liabilities, Current in USD history and change rate from 30 Sep 2013 to 30 Jun 2023.
- EAGLE PHARMACEUTICALS, INC. Liabilities, Current for the quarter ending 30 Jun 2023 was $86,630,000, a 20% decline year-over-year.
- Source SEC data
- View on sec.gov
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Change (%)
EAGLE PHARMACEUTICALS, INC. Quarterly Liabilities, Current (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q2 2023 | $86,630,000 | -$22,334,000 | -20% | 30 Jun 2023 | 10-Q/A | 09 Aug 2023 | 2023 | Q2 |
| Q1 2023 | $97,809,000 | -$3,833,000 | -3.8% | 31 Mar 2023 | 10-Q | 09 May 2023 | 2023 | Q1 |
| Q4 2022 | $111,087,000 | +$36,711,000 | +49% | 31 Dec 2022 | 10-Q/A | 09 Aug 2023 | 2023 | Q2 |
| Q3 2022 | $121,828,000 | +$73,397,000 | +152% | 30 Sep 2022 | 10-Q | 09 Nov 2022 | 2022 | Q3 |
| Q2 2022 | $108,964,000 | +$64,300,000 | +144% | 30 Jun 2022 | 10-Q | 09 Aug 2022 | 2022 | Q2 |
| Q1 2022 | $101,642,000 | +$59,669,000 | +142% | 31 Mar 2022 | 10-Q | 09 May 2022 | 2022 | Q1 |
| Q4 2021 | $74,376,000 | +$36,291,000 | +95% | 31 Dec 2021 | 10-K | 23 Mar 2023 | 2022 | FY |
| Q3 2021 | $48,431,000 | +$2,918,000 | +6.4% | 30 Sep 2021 | 10-Q | 09 Nov 2021 | 2021 | Q3 |
| Q2 2021 | $44,664,000 | +$4,178,000 | +10% | 30 Jun 2021 | 10-Q | 09 Aug 2021 | 2021 | Q2 |
| Q1 2021 | $41,973,000 | -$103,906,000 | -71% | 31 Mar 2021 | 10-Q | 10 May 2021 | 2021 | Q1 |
| Q4 2020 | $38,085,000 | -$738,000 | -1.9% | 31 Dec 2020 | 10-K | 08 Mar 2022 | 2021 | FY |
| Q3 2020 | $45,513,000 | +$3,154,000 | +7.4% | 30 Sep 2020 | 10-Q | 02 Nov 2020 | 2020 | Q3 |
| Q2 2020 | $40,486,000 | -$11,260,000 | -22% | 30 Jun 2020 | 10-Q | 10 Aug 2020 | 2020 | Q2 |
| Q1 2020 | $145,879,000 | +$101,657,000 | +230% | 31 Mar 2020 | 10-Q | 11 May 2020 | 2020 | Q1 |
| Q4 2019 | $38,823,000 | -$863,000 | -2.2% | 31 Dec 2019 | 10-K | 05 Mar 2021 | 2020 | FY |
| Q3 2019 | $42,359,000 | +$6,948,000 | +20% | 30 Sep 2019 | 10-Q | 12 Nov 2019 | 2019 | Q3 |
| Q2 2019 | $51,746,000 | +$4,008,000 | +8.4% | 30 Jun 2019 | 10-Q | 08 Aug 2019 | 2019 | Q2 |
| Q1 2019 | $44,222,000 | +$15,462,000 | +54% | 31 Mar 2019 | 10-Q | 07 May 2019 | 2019 | Q1 |
| Q4 2018 | $39,686,000 | -$7,616,000 | -16% | 31 Dec 2018 | 10-K | 02 Mar 2020 | 2019 | FY |
| Q3 2018 | $35,411,000 | +$1,016,000 | +3% | 30 Sep 2018 | 10-Q | 01 Nov 2018 | 2018 | Q3 |
| Q2 2018 | $47,738,000 | +$15,785,000 | +49% | 30 Jun 2018 | 10-Q | 07 Aug 2018 | 2018 | Q2 |
| Q1 2018 | $28,760,000 | -$6,678,000 | -19% | 31 Mar 2018 | 10-Q | 10 May 2018 | 2018 | Q1 |
| Q4 2017 | $47,302,000 | +$6,337,000 | +15% | 31 Dec 2017 | 10-K | 28 Feb 2019 | 2018 | FY |
| Q3 2017 | $34,395,000 | -$1,052,000 | -3% | 30 Sep 2017 | 10-Q | 08 Nov 2017 | 2017 | Q3 |
| Q2 2017 | $31,953,000 | -$3,826,000 | -11% | 30 Jun 2017 | 10-Q | 09 Aug 2017 | 2017 | Q2 |
| Q1 2017 | $35,438,000 | +$4,570,000 | +15% | 31 Mar 2017 | 10-Q | 08 May 2017 | 2017 | Q1 |
| Q4 2016 | $40,965,000 | +$6,703,000 | +20% | 31 Dec 2016 | 10-K | 26 Feb 2018 | 2017 | FY |
| Q3 2016 | $35,447,000 | +$860,000 | +2.5% | 30 Sep 2016 | 10-Q | 09 Nov 2016 | 2016 | Q3 |
| Q2 2016 | $35,779,000 | +$11,198,000 | +46% | 30 Jun 2016 | 10-Q | 09 Aug 2016 | 2016 | Q2 |
| Q1 2016 | $30,868,000 | +$3,819,000 | +14% | 31 Mar 2016 | 10-Q | 10 May 2016 | 2016 | Q1 |
| Q4 2015 | $34,262,000 | +$12,076,000 | +54% | 31 Dec 2015 | 10-K | 15 Mar 2017 | 2016 | FY |
| Q3 2015 | $34,587,000 | +$14,272,000 | +70% | 30 Sep 2015 | 10-Q | 12 Nov 2015 | 2015 | Q3 |
| Q2 2015 | $24,581,000 | +$8,332,030 | +51% | 30 Jun 2015 | 10-Q | 11 Aug 2015 | 2015 | Q2 |
| Q1 2015 | $27,049,000 | +$7,780,545 | +40% | 31 Mar 2015 | 10-Q | 15 May 2015 | 2015 | Q1 |
| Q4 2014 | $22,186,000 | 31 Dec 2014 | 10-K | 29 Feb 2016 | 2015 | FY | ||
| Q3 2014 | $20,315,000 | +$5,973,000 | +42% | 30 Sep 2014 | 10-K | 29 Feb 2016 | 2015 | FY |
| Q2 2014 | $16,248,970 | 30 Jun 2014 | 10-Q | 11 Aug 2014 | 2014 | Q3 | ||
| Q1 2014 | $19,268,455 | 31 Mar 2014 | 10-Q | 15 May 2014 | 2014 | Q2 | ||
| Q3 2013 | $14,342,000 | 30 Sep 2013 | 10-K | 22 Dec 2014 | 2014 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.